Clinical Trials Logo

Clinical Trial Summary

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from pancreatic masses. A new core biopsy needle has been developed by Beacon bnx® (Medtronic, Newton, MA) that allows the possibility to achieve a core for histology evaluation and the interchangibility of needle size using the same needle shelter and different needle sizes.


Clinical Trial Description

At every pass, the material will be fixed in formalin. Three passes will be done. Details of the aspirated material will be described at macroscopic evaluation by the endoscopist and then by the pathologist at macroscopic and microscopic evaluation, in order to find an interobserved agreement on the definition of the core. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02946840
Study type Observational
Source Istituto Clinico Humanitas
Contact
Status Completed
Phase
Start date August 2016
Completion date May 2018

See also
  Status Clinical Trial Phase
Completed NCT01016288 - Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles (FNA-22G-25G) N/A
Completed NCT02167074 - Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS N/A
Completed NCT01576497 - Optimal Number of To-and-fro Motion in EUS-guided Fine Needle Aspiration for Pancreatic Masses Phase 3